Device Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants.

Autor:	Baruteau AE; Department of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, Nantes, France.; Nantes Université, CHU Nantes, INSERM, CIC FEA 1413, Nantes, France.; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.; Nantes Université, INRAE, UMR 1280, PhAN, Nantes, France., Méot M; M3C-Necker, Department of Pediatric and Congenital Cardiology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Benbrik N; Department of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, Nantes, France., Grunenwald C; Department of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, Nantes, France., Lwin N; Department of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, Nantes, France.; Nantes Université, CHU Nantes, INSERM, CIC FEA 1413, Nantes, France., Patkai J; Department of Neonatal Medicine, Cochin-Port Royal Hospital, FHU PREMA, APHP, Paris, France., Rozé JC; Nantes Université, CHU Nantes, INSERM, CIC FEA 1413, Nantes, France., Bonnet D; M3C-Necker, Department of Pediatric and Congenital Cardiology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; University Paris Cité, Paris, France., Malekzadeh-Milani S; M3C-Necker, Department of Pediatric and Congenital Cardiology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Jazyk:	angličtina
Zdroj:	JACC. Advances [JACC Adv] 2024 Aug 24; Vol. 3 (10), pp. 101211. Date of Electronic Publication: 2024 Aug 24 (Print Publication: 2024).
DOI:	10.1016/j.jacadv.2024.101211
Abstrakt:	The patent ductus arteriosus is a very common condition in preterm infants, and a hemodynamically significant patent ductus arteriosus increases morbidity and mortality in these vulnerable patients. However, despite numerous randomized controlled trials, there is no consensus regarding management. Medical therapy is typically offered as first-line treatment, although it yields limited success and carries the potential for severe adverse events. In recent years, there has been rapid development in transcatheter patent ductus arteriosus closure primary with the use of the Amplatzer Piccolo Occluder, and this has gained widespread acceptance as a safe and effective alternative to surgical ligation in extremely low-birth-weight infants weighing over 700 g. This article aims to provide an appraisal of the patient selection process, a step-by-step procedural guide, and a comprehensive review of the outcomes associated with this approach. Competing Interests: Dr Alban-Elouen Baruteau is supported by the French Government as part of the “Investments of the Future” program managed by the National Research Agency (grant reference ANR-16-IDEX-0007); and is a consultant and proctor for Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. (© 2024 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu